Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
12.8M
-
Shares change
-
-36.1K
-
Total reported value, excl. options
-
$36.4M
-
Value change
-
+$156K
-
Put/Call ratio
-
0.07
-
Number of buys
-
25
-
Number of sells
-
-31
-
Price
-
$2.85
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2022
76 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2022.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.8M shares
of 43.4M outstanding shares and own 29.4% of the company stock.
Largest 10 shareholders include Slate Path Capital LP (2.4M shares), Prosight Management, LP (1.84M shares), VANGUARD GROUP INC (1.53M shares), Bleichroeder LP (861K shares), BlackRock Inc. (702K shares), Monaco Asset Management SAM (497K shares), Robertson Stephens Wealth Management, LLC (479K shares), DIMENSIONAL FUND ADVISORS LP (458K shares), MILLENNIUM MANAGEMENT LLC (374K shares), and CARLSON CAPITAL L P (365K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.